Append Medical announce the appointment of Shlomi Nachman as Chairman of the Board. This strategic move reflects the company's commitment to advancing its mission of reducing stroke risks for patients with atrial fibrillation through groundbreaking technology.

Nachman brings over 25 years of experience in the medical device industry, having held senior leadership roles at Johnson & Johnson, where he served as Company Group Chairman of Cardiovascular and Specialty Solutions and Vision Groups. His extensive expertise spans diverse therapeutic areas, including electrophysiology, neurovascular intervention, and cardiovascular, making him uniquely positioned to guide Append Medical's growth and innovation.

"We are thrilled to welcome Shlomi Nachman as our Chairman," said Nadav Agian, CEO of Append Medical. "His proven track record in driving commercial success and fostering innovation will be instrumental as we scale our proprietary transcatheter solutions to address unmet clinical needs."

Mr. Nachman expressed his enthusiasm for joining Append Medical: "I am honored to lead the board of a company that is transforming stroke prevention with its disruptive technology. I look forward to collaborating with the talented team at Append Medical to make a lasting impact on patient care."

Append Medical's proprietary vacuum-based LAA occlusion system eliminates the need for implants in the heart, addressing key risks such as Device-Related Thromboembolism (DRT) and Peri-Device Leakage (PDL). The company is poised to revolutionize stroke prevention therapies globally.